Abstract
Antecedent The diagnosis of schizophrenia could be enhanced with objective neurophysiological biomarkers, such as the event related potential features in conjunction with machine learning procedures. A previous work extracted features from event related responses to three oddball paradigms (auditory and visual P300, and mismatch negativity) for the discrimination of schizophrenic patients. They used several classifiers: Naïve Bayes, Support Vector Machine, Decision Tree, Adaboost and Random Forest. The best accuracy was obtained with Random Forest (84.7%).
Objective The aim of this study was to examine the efficacy of Multiple Kernel Learning classifiers and Boruta feature selection method exploring different features for single-subject classification between schizophrenia patients and healthy controls.
Methods A cohort of 54 schizophrenic subjects and 54 healthy control subjects were studied. Three sets of features related to the event related potentials signal were calculated: Peak related features, Peak to Peak related features and Signal related features. The Boruta feature selection algorithm was used to evaluate its impact on classification accuracy. A Multiple Kernel Learning algorithm was applied to address schizophrenia detection.
Results We obtained a classification accuracy of 83% using Multiple Kernel Learning classifier with the whole dataset. This result in accuracy triangulates previous work and shows that the differences between schizophrenic patients and controls are robust even when different classifiers are used. Appling the Boruta feature selection algorithm a classification accuracy of 86% was yielded. The variables that contributed most to the classification were mainly related to the latency and amplitude of the auditory P300.
Conclusion This study showed that Multiple Kernel Learning can be useful in distinguishing between schizophrenic patients and controls. Moreover, the combination with the Boruta algorithm provides an improvement in classification accuracy and computational cost.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the VLIR-UOS project 'A Cuban National School of Neurotechnology for Cognitive Aging'(NSNCA), Grant number CU2017TEA436A103.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethic Comitee of Cuban Neuroscience Center gave ethical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the manuscript
